Ancillary supplies are a necessary component in every clinical trial, though these products are often perceived as secondary in importance to investigational medicinal products (IMPs). As trials have become increasingly global and complex, ancillaries have grown in volume, type, visibility and expectation. And while the focus on a study drug is understandable, not paying ancillaries the attention they require can be a costly mistake. Download this article to learn why ancillaries are as essential as IMPs, and why sponsors should devote as much attention to early planning for ancillary supplies as they do for study drugs. | 
